{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T17:51:21Z","timestamp":1785865881337,"version":"3.56.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,6,7]],"date-time":"2017-06-07T00:00:00Z","timestamp":1496793600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the Ministry of Education, Culture, Sports, and Technology in Japan","award":["16K10146"],"award-info":[{"award-number":["16K10146"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s00403-017-1749-9","type":"journal-article","created":{"date-parts":[[2017,6,7]],"date-time":"2017-06-07T11:25:18Z","timestamp":1496834718000},"page":"491-497","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["BET bromodomain inhibitor JQ1 decreases CD30 and CCR4 expression and proliferation of cutaneous T-cell lymphoma cell lines"],"prefix":"10.1007","volume":"309","author":[{"given":"Hiroaki","family":"Kamijo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1618-329X","authenticated-orcid":false,"given":"Makoto","family":"Sugaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomitsu","family":"Miyagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihide","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,7]]},"reference":[{"key":"1749_CR1","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrc3256","volume":"12","author":"AC Belkina","year":"2012","unstructured":"Belkina AC, Denis GV (2012) BET domain co-regulators in obesity, inflammation and cancer. Nat Rev Cancer 12:465\u2013477","journal-title":"Nat Rev Cancer"},{"key":"1749_CR2","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nature03841","volume":"436","author":"M Braig","year":"2005","unstructured":"Braig M, Lee S, Loddenkemper C et al (2005) Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436:660\u2013665","journal-title":"Nature"},{"key":"1749_CR3","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1182\/blood-2014-09-600924","volume":"125","author":"M Duvic","year":"2015","unstructured":"Duvic M, Pinter-Brown LC, Foss FM et al (2015) Phase 1\/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma. Blood 125:1883\u20131889","journal-title":"Blood"},{"issue":"6066","key":"1749_CR4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1126\/science.1217819","volume":"335","author":"G Evan","year":"2012","unstructured":"Evan G (2012) Cancer. Taking a back door to target Myc. Science 335(6066):293\u2013294","journal-title":"Science"},{"key":"1749_CR5","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature09504","volume":"468","author":"P Filippakopoulos","year":"2010","unstructured":"Filippakopoulos P, Qi J, Picaud S et al (2010) Selective inhibition of BET bromodomains. Nature 468:1067\u20131073","journal-title":"Nature"},{"key":"1749_CR6","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.18632\/oncotarget.3551","volume":"6","author":"LL Fu","year":"2015","unstructured":"Fu LL, Tian M, Li X et al (2015) Inhibition of BET bromodomains as a therapeutic strategy for cancer drug discovery. Oncotarget 6:5501\u20135516","journal-title":"Oncotarget"},{"key":"1749_CR7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1517\/13543784.2014.876407","volume":"23","author":"E Guenova","year":"2014","unstructured":"Guenova E, Hoetzenecker W, Rozati S et al (2014) Novel therapies for cutaneous T-cell lymphoma: what does the future hold? Expert Opin Investig Drugs 23:457\u2013467","journal-title":"Expert Opin Investig Drugs"},{"key":"1749_CR8","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0344-0338(11)80423-1","volume":"190","author":"P Kanavaros","year":"1994","unstructured":"Kanavaros P, Ioannidou D, Tzardi M et al (1994) Mycosis fungoides: expression of C-myc p62 p53, bcl-2 and PCNA proteins and absence of association with Epstein-Barr virus. Pathol Res Pr 190:767\u2013774","journal-title":"Pathol Res Pr"},{"key":"1749_CR9","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1200\/JCO.2014.60.3969","volume":"33","author":"YH Kim","year":"2015","unstructured":"Kim YH, Tavallaee M, Sundram U et al (2015) Phase II investigator-initiated study of brentuximab vedotin in mycosis fungoides and S\u00e9zary syndrome with variable CD30 expression level: a multi-institution collaborative project. J Clin Oncol 33:3750\u20133758","journal-title":"J Clin Oncol"},{"key":"1749_CR10","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1038\/onc.2015.435","volume":"35","author":"A Kitadate","year":"2016","unstructured":"Kitadate A, Ikeda S, Teshima K et al (2016) MicroRNA-16 mediates the regulation of a senescence-apoptosis switch in cutaneous T-cell and other non-Hodgkin lymphomas. Oncogene 35:3692\u20133704","journal-title":"Oncogene"},{"key":"1749_CR11","doi-asserted-by":"crossref","first-page":"895","DOI":"10.5114\/aoms.2013.38684","volume":"9","author":"J Maj","year":"2013","unstructured":"Maj J, Jankowska-Konsur A, Plomer-Niezgoda E et al (2013) Altered expression of Bcl-2, c-Myc, H-Ras, K-Ras, and N-Ras does not influence the course of mycosis fungoides. Arch Med Sci 9:895\u2013898","journal-title":"Arch Med Sci"},{"issue":"5","key":"1749_CR12","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/jid.2012.10","volume":"132","author":"V Manf\u00e9","year":"2012","unstructured":"Manf\u00e9 V, Biskup E, Johansen P et al (2012) MDM2 inhibitor nutlin-3a induces apoptosis and senescence in cutaneous T-cell lymphoma: role of p53. J Investig Dermatol 132(5):1487\u20131496","journal-title":"J Investig Dermatol"},{"key":"1749_CR13","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1200\/JCO.2001.19.2.376","volume":"19","author":"E Olsen","year":"2001","unstructured":"Olsen E, Duvic M, Frankel A et al (2001) Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma. J Clin Oncol 19:376\u2013388","journal-title":"J Clin Oncol"},{"key":"1749_CR14","doi-asserted-by":"crossref","first-page":"a018663","DOI":"10.1101\/cshperspect.a018663","volume":"6","author":"J Qi","year":"2014","unstructured":"Qi J (2014) Bromodomain and extraterminal domain inhibitors (BETi) for cancer therapy: chemical modulation of chromatin structure. Cold Spring Harb Perspect Biol 6:a018663","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1749_CR15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jdermsci.2012.07.007","volume":"68","author":"M Sugaya","year":"2012","unstructured":"Sugaya M, Miyagaki T, Ohmatsu H et al (2012) Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma. J Dermatol Sci 68:45\u201351","journal-title":"J Dermatol Sci"},{"key":"1749_CR16","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","volume":"105","author":"R Willemze","year":"2005","unstructured":"Willemze R, Jaffe ES, Burg G et al (2005) WHO-EORTC classification for cutaneous lymphomas. Blood 105:3768\u20133785","journal-title":"Blood"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-017-1749-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-017-1749-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-017-1749-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,13]],"date-time":"2017-07-13T06:28:23Z","timestamp":1499927303000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-017-1749-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,7]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["1749"],"URL":"https:\/\/doi.org\/10.1007\/s00403-017-1749-9","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,7]]}}}